J. Andrews

2.0k total citations
56 papers, 1.6k citations indexed

About

J. Andrews is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, J. Andrews has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Pharmacology and 10 papers in Cancer Research. Recurrent topics in J. Andrews's work include Hemophilia Treatment and Research (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Virus-based gene therapy research (8 papers). J. Andrews is often cited by papers focused on Hemophilia Treatment and Research (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Virus-based gene therapy research (8 papers). J. Andrews collaborates with scholars based in United Kingdom, United States and Canada. J. Andrews's co-authors include Sheila Connelly, Michael Kaleko, Nancy J. Gorelick, Kathryn E. Kenworthy, J. D. Williams, J. Brian Houston, Stephen E. Clarke, Robert A. Wise, Antony D’Emanuele and M Gorziglia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

J. Andrews

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Andrews United Kingdom 22 675 416 317 190 186 56 1.6k
Robert S. Jansen Netherlands 25 859 1.3× 441 1.1× 548 1.7× 96 0.5× 105 0.6× 64 2.1k
Minya Pu United States 29 646 1.0× 325 0.8× 674 2.1× 94 0.5× 359 1.9× 74 2.4k
Haihong Zhu China 28 651 1.0× 268 0.6× 200 0.6× 84 0.4× 314 1.7× 96 1.9k
Alexandre Evrard France 25 841 1.2× 143 0.3× 711 2.2× 81 0.4× 221 1.2× 80 1.9k
Tiffany Tsang United States 19 700 1.0× 245 0.6× 277 0.9× 49 0.3× 190 1.0× 34 1.9k
Ken Satoh Japan 27 768 1.1× 130 0.3× 419 1.3× 37 0.2× 301 1.6× 88 1.9k
Axel Sauerbrey Germany 25 1.3k 1.9× 113 0.3× 1.1k 3.4× 103 0.5× 260 1.4× 72 2.6k
D H Ho United States 27 887 1.3× 90 0.2× 768 2.4× 405 2.1× 119 0.6× 100 2.5k
Davide Serrano Italy 31 919 1.4× 700 1.7× 955 3.0× 113 0.6× 602 3.2× 97 2.7k
Giuliana Giribaldi Italy 29 798 1.2× 106 0.3× 241 0.8× 65 0.3× 181 1.0× 67 2.6k

Countries citing papers authored by J. Andrews

Since Specialization
Citations

This map shows the geographic impact of J. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Andrews more than expected).

Fields of papers citing papers by J. Andrews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Andrews. The network helps show where J. Andrews may publish in the future.

Co-authorship network of co-authors of J. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of J. Andrews. A scholar is included among the top collaborators of J. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Andrews. J. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horn, Leora, et al.. (2011). DIRECT: DNA-mutation Inventory to Refine and Enhance Cancer Treatment—A catalogue of clinically relevant somatic mutations in lung cancer.. Journal of Clinical Oncology. 29(15_suppl). 7575–7575. 8 indexed citations
2.
Hakooz, Nancy, Tawfiq Arafat, Debbie Payne, et al.. (2010). Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population. European Journal of Clinical Pharmacology. 66(10). 999–1003. 14 indexed citations
3.
Higgs, Jenny, J. Andrews, David Gurwitz, Katherine Payne, & William G. Newman. (2008). Pharmacogenetics education in British medical schools. PubMed. 2(3-4). 101–105. 38 indexed citations
4.
5.
Peng, Bin, J. Andrews, Ivan Nestorov, et al.. (2001). Tissue Distribution and Physiologically Based Pharmacokinetics of Antisense Phosphorothioate Oligonucleotide ISIS 1082 in Rat. Antisense and Nucleic Acid Drug Development. 11(1). 15–27. 33 indexed citations
6.
Andrews, J.. (1999). Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997. Journal of Antimicrobial Chemotherapy. 43(5). 689–698. 26 indexed citations
7.
Shirley, Pamela S., J. Andrews, Dawn B. Kayda, et al.. (1999). In Vivo Evaluation of an Adenoviral Vector Encoding Canine Factor VIII: High-Level, Sustained Expression in Hemophiliac Mice. Human Gene Therapy. 10(11). 1791–1802. 36 indexed citations
8.
Walker, Vernon E., J. Andrews, Patricia B. Upton, et al.. (1999). Detection of cyclophosphamide-induced mutations at theHprt but not thelacI locus in splenic lymphocytes of exposed mice. Environmental and Molecular Mutagenesis. 34(2-3). 167–181. 27 indexed citations
9.
Gorelick, Nancy J., et al.. (1997). Evaluation of lacI mutation in germ cells and micronuclei in peripheral blood after treatment of male lacI transgenic mice with ethylnitrosourea, isopropylmethane sulfonate or methylmethane sulfonate. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 388(2-3). 187–195. 5 indexed citations
10.
Andrews, J., et al.. (1997). The Use of Sonication for the Efficient Delivery of Plasmid DNA into Cells. Pharmaceutical Research. 14(6). 750–756. 63 indexed citations
11.
Stuart, Gregory R., Nancy J. Gorelick, J. Andrews, Johan G. de Boer, & Barry W. Glickman. (1996). System issues: The genetic analysis oflacl mutations in sectored plaques from Big Blue® transgenic mice. Environmental and Molecular Mutagenesis. 28(4). 385–392. 20 indexed citations
12.
Gorelick, Nancy J., et al.. (1995). Mutational spectra in the lacl gene in skin from 7, 12‐dimethylbenz[a]anthracene‐treated and untreated transgenic mice. Molecular Carcinogenesis. 14(1). 53–62. 50 indexed citations
13.
Andrews, J., et al.. (1995). The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. Journal of Antimicrobial Chemotherapy. 35(6). 869–876. 76 indexed citations
14.
15.
Andrews, J., et al.. (1994). Loss of salt-tolerance and transformation efficiency in Escherichia coli associated with sub-lethal injury by centrifugation. Letters in Applied Microbiology. 19(5). 312–316. 8 indexed citations
16.
Jiménez, M. Ángeles, John R. P. Arnold, J. Andrews, et al.. (1989). Dihydrofolate reductase: control of the mode of substrate binding by aspartate 26. Protein Engineering Design and Selection. 2(8). 627–631. 5 indexed citations
17.
Birdsall, B., J. Andrews, Saul J. B. Tendler, et al.. (1989). NMR studies of differences in the conformations and dynamics of ligand complexes formed with mutant dihydrofolate reductases. Biochemistry. 28(3). 1353–1362. 20 indexed citations
18.
Andrews, J., Carol A. Fierke, B. Birdsall, et al.. (1989). A kinetic study of wild-type and mutant dihydrofolate reductases from Lactobacillus casei. Biochemistry. 28(14). 5743–5750. 45 indexed citations
19.
Brown, Robert, Robert A. Wise, J. Andrews, & Jules C. Hancox. (1982). Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.. Europe PMC (PubMed Central).
20.
Williams, J. D. & J. Andrews. (1974). Sensitivity of Haemophilus influenzae to Antibiotics. BMJ. 1(5899). 134–137. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Jansen Breakdown of academic impact, for papers by Minya Pu Breakdown of academic impact, for papers by Haihong Zhu Breakdown of academic impact, for papers by Alexandre Evrard Breakdown of academic impact, for papers by Tiffany Tsang Breakdown of academic impact, for papers by Ken Satoh Breakdown of academic impact, for papers by Axel Sauerbrey Breakdown of academic impact, for papers by D H Ho Breakdown of academic impact, for papers by Davide Serrano Breakdown of academic impact, for papers by Giuliana Giribaldi
Rankless by CCL
2026